CYP 5.56% 19.0¢ cynata therapeutics limited

Ann: Investor Presentation, page-259

  1. 216 Posts.
    lightbulb Created with Sketch. 35
    Note: Mesoblast have only done 1 single arm trial in GvHD in over 10 years (54) Children - Cost them $500m so far and Gavins shirt off his back
    Cynata will surpass this number by end of year, if not by October in GvHD 15 + 60 (75) Adults

    Cynata has officially treated more Adult GvHD patients in proper US trials than Mesoblast.



 
watchlist Created with Sketch. Add CYP (ASX) to my watchlist
(20min delay)
Last
19.0¢
Change
0.010(5.56%)
Mkt cap ! $34.32M
Open High Low Value Volume
18.0¢ 19.5¢ 18.0¢ $9.062K 48.88K

Buyers (Bids)

No. Vol. Price($)
2 104632 18.5¢
 

Sellers (Offers)

Price($) Vol. No.
19.0¢ 3 1
View Market Depth
Last trade - 14.37pm 12/09/2024 (20 minute delay) ?
CYP (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.